- £2.13bn
- £2.32bn
- £1.91bn
- 88
- 50
- 25
- 54
Annual income statement for Qinetiq, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,073 | 1,278 | 1,320 | 1,581 | 1,912 |
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 949 | 1,159 | 1,193 | 1,382 | 1,714 |
| Operating Profit | 124 | 119 | 127 | 199 | 198 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 123 | 146 | 126 | 192 | 183 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 107 | 125 | 90 | 154 | 140 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 106 | 125 | 90 | 154 | 140 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 106 | 125 | 90 | 154 | 140 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.192 | 0.208 | 0.145 | 0.233 | 0.295 |
| Dividends per Share |